Russian Pharmaceutical Industry Leader

Products

Instolit
Pharmacotherapeutic group
Oral hypoglycemic agent, third generation sulfonylurea derivative
International name
Glimepiride
Dosage form
Tablets
Description Manufacturer Leave a feedback
Oral hypoglycemic drug, sulfonylurea derivative. Glibenclamide stimulates insulin secretion by pancreatic beta cells and increases insulin release. It also increases sensitivity of peripheral tissues to insulin.
Send
NAME AND SURNAME*
E-mail
Subject*
Message*
Captcha*
* — Required field